Cargando…
Assessment of primary prevention patients receiving an ICD – Systematic evaluation of ATP: APPRAISE ATP
BACKGROUND: The value of antitachycardia pacing (ATP) in the overall cohort of primary prevention patients who receive implantable cardioverter-defibrillators (ICDs) remains uncertain. ATP success reported in prior trials potentially included a large number of patients receiving unnecessary ATP for...
Autores principales: | Schuger, Claudio D., Ando, Kenji, Cantillon, Daniel J., Lambiase, Pier D., Mont, Lluis, Joung, Bo Young, Peress, Darren, Yong, Patrick, Wold, Nicholas, Daubert, James P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369290/ https://www.ncbi.nlm.nih.gov/pubmed/34430946 http://dx.doi.org/10.1016/j.hroo.2021.07.003 |
Ejemplares similares
-
Design and rationale of the MODULAR ATP global clinical trial: A novel intercommunicative leadless pacing system and the subcutaneous implantable cardioverter-defibrillator
por: Lloyd, Michael S., et al.
Publicado: (2023) -
Rationale and design of the EU‐CERT‐ICD prospective study: comparative effectiveness of prophylactic ICD implantation
por: Zabel, Markus, et al.
Publicado: (2018) -
Early Experience with the Subcutaneous ICD
por: Lambiase, Pier D., et al.
Publicado: (2014) -
To ATP or Not To ATP: This Is the Question
por: Accardi, Alessio
Publicado: (2008) -
To ATP or Not To ATP: This Is the Question
por: Accardi, Alessio
Publicado: (2008)